|
Press Releases |
|
|
|
Wednesday, August 27, 2014 |
|
上海醫藥2014年中期收入及利潤實現兩位數增長 |
中國醫藥產品製造及分銷市場領先的一體化醫藥公司 - 上海醫藥集團股份有限公司 (「上海醫藥」或「公司」,連同其附屬公司「集團」,股份代號:601607.SH;2607.HK),今天發佈2014年中期報告,報告顯示,2014年上半年,公司實現營業收入人民幣440.13億元,同比增長13.68%。 more info >> |
|
Shanghai Pharmaceuticals Achieves Double-Digit Growth of Revenue and Profit for 1H2014 |
Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical product and distribution markets more info >> |
|
Monday, March 31, 2014 |
|
上海医药2013年业绩 |
上海医药集团股份有限公司2013年公司实现营业收入为人民币782.23亿元,同比增长14.90%。实现归属于上市公司股东净利润为人民币22.43亿元,同比增长9.26%,扣除非经常性损益后增速达到15.16%。 more info >> |
|
上海醫藥2013年業績 |
上海醫藥集團股份有限公司2013年公司實現營業收入為人民幣782.23億元,同比增長14.90%。實現歸屬於上市公司股東淨利潤為人民幣22.43億元,同比增長9.26%,扣除非經常性損益後增速達到15.16%。
more info >> |
|
Shanghai Pharmaceuticals 2013 Annual Results |
Shanghai Pharmaceuticals Holding Co. Ltd. recorded operating revenue of RMB78.223 billion, up by 14.90% on a YOY basis. Net profit attributable to the equity holders of the listed Company was RMB2.243 billion, up by 9.26% on a YOY basis, and reached a growth of 15.16% after deducting non-recurring profit or loss. more info >> |
|
Wednesday, March 27, 2013 |
|
上药2012年净利润为人民币20.53亿元 |
上海医药于2012年录得理想业务表现,收入增加24%至680.78亿人民币,属于上市公司股东净利润为人民币20.53亿元,在扣除广东天普生化医药股份有限公司一次性特殊收益、及H股上市募集资金汇兑净损失后,归属于上市公司股东净利润较上年同期增长达13.5%。 more info >> |
|
上藥2012年淨利潤為人民幣20.53億元 |
上海醫藥於2012年錄得理想業務表現,收入增加24%至680.78億人民幣,屬於上市公司股東淨利潤為人民幣20.53億元,在扣除廣東天普生化醫藥股份有限公司一次性特殊收益、及H股上市募集資金匯兌淨損失後,歸屬於上市公司股東淨利潤較上年同期增長達13.5%。 more info >> |
|
Wednesday, April 20, 2011 |
|
上海医药与辉瑞就潜在战略伙伴关系签署谅解备忘录 |
上海医药集团股份有限公司(上交所股票代号:601607)与辉瑞公司(纽交所股票代号:PFE)今天宣布签署一份谅解备忘录,以共同寻求在中国的潜在的业务机会。 more info >> |
|
上海醫藥與輝瑞就潛在戰略夥伴關係簽署諒解備忘錄 |
上海醫藥集團股份有限公司(上交所股票代號:601607)與輝瑞公司(紐交所股票代號:PFE)今天宣佈簽署一份諒解備忘錄,以共同尋求在中國的潛在的業務機會。 more info >> |
|
Pfizer and Shanghai Pharmaceutical Sign Memorandum of Understanding for Potential Strategic Partnership |
Shanghai Pharmaceutical Co. Ltd. (SHSE: 601607) and Pfizer Inc. (NYSE: PFE) today announced the signing of a memorandum of understanding (MOU) for the companies to jointly pursue potential business opportunities in China. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Shaping the Future of Technology with AI Everywhere Take Center Stage at the 13th Big CIO Show
May 10, 2024 20:55 HKT/SGT
|
|
|
DOCOMO to Launch "NTT DOCOMO GLOBAL" for Global Expansion
May 10, 2024 18:13 JST
|
|
|
Japan Energy Summit and Exhibition Hosts and Sponsors Demonstrate the Importance of Accelerating Decarbonisation
May 10, 2024 16:04 HKT/SGT
|
|
|
Pertamina International Shipping (PIS) Welcomes 2 VLGC Tankers to Its Fleet, Takes Top-Tier Position in ASEAN LPG Transport
May 10, 2024 16:00 HKT/SGT
|
|
|
Q2 Metals Announces Assay Results from Its 2024 Winter Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada
May 10, 2024 15:09 HKT/SGT
|
|
|
三菱重工など、電力系統の混雑緩和を実現するシステムのフィールド実証を開始
May 10, 2024 11:50: JST
|
|
|
Release of "Fugaku-LLM" - a large language model trained on the supercomputer "Fugaku"
May 10, 2024 12:20 JST
|
|
|
InfoComm Asia 2024 "Asia's International Pro AV Exhibition" Returns to Thailand
May 10, 2024 10:30 HKT/SGT
|
|
|
BLUETTI Unlocks Special Mother's Day Offerings, Perfect Gift Ideas for Moms
May 10, 2024 10:00 HKT/SGT
|
|
|
AGILON HEALTH (NYSE: AGL) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Agilon Health Investors of a Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
May 10, 2024 08:33 HKT/SGT
|
|
|
SSR MINING (SSRM) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies SSR Mining Investors of a Class Action Lawsuit and May 17, 2024 Lead Plaintiff Deadline
May 10, 2024 08:26 HKT/SGT
|
|
|
CHEMOURS (NYSE: CC) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
May 10, 2024 08:20 HKT/SGT
|
|
|
DOXIMITY (NYSE: DOCS) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and June 17, 2024 Lead Plaintiff Deadline
May 10, 2024 08:13 HKT/SGT
|
|
|
特步宣布战略性出售K-Swiss及帕拉丁 并优化财务结构
May 9, 2024 20:28 HKT/SGT
|
|
|
特步宣佈戰略性出售K-Swiss及帕拉丁 並優化財務結構
May 9, 2024 20:25 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|